Answers are grounded in this paper and cite their sources.
Minimal residual disease-negative status after treatment for newly diagnosed MM is associated with long-term survival. These findings provide quantitative evidence to support the integration of MRD assessment as an end point in clinical trials of MM.
No takes yet. Share an insight, caveat, or question.
Munshi et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: